OncoImmune, Inc.;University of North Carolina at Chapel Hill;Institute of Biophysics, Chinese Academy of Sciences;Kunming Institute of Zoology, Chinese Academy of Sciences
The present invention relates to a method of treating, mitigating, minimizing, or preventing HIV-1/AIDS by administering a CD24 protein to a subject in need thereof. Also provided herein is use of a CD24 protein in the manufacture of a medicament for treating HIV-1/AIDS. Further, provided is a pharmaceutical composition comprising a pharmaceutically acceptable amount of a CD24 protein.